# Study of Bacopa in Gulf War Illness Patients

> **NCT04927338** · PHASE2 · RECRUITING · sponsor: **Nova Southeastern University** · enrollment: 170 (estimated)

## Conditions studied

- Gulf War Illness

## Interventions

- **DIETARY_SUPPLEMENT:** BacoMind® (Bacopa monnieri standardized extract)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04927338
- **Lead sponsor:** Nova Southeastern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04927338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04927338, "Study of Bacopa in Gulf War Illness Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04927338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*